In particular, TGF- β and IL-10 mediate an anti-inflammatory response by dampening the activity of tumor suppressor cells, such as cytotoxic T lymphocytes (CTLs) and NK cells, and enhancing the activity of tumor-promoting cells such as Tregs and tumor-associated neutrophils (TANs) [28,29]. The gene discussed is IL10; the disease is neoplasm.